Tempus AI Acquires Personalis for $1.5 Billion Boost in Precision Oncology
Estimated reading time: 5 minutes Tempus AI Acquires Personalis: A $1.5 Billion Game Changer for Precision Oncology Tempus AI is acquiring Personalis for approximately $1.5 billion. The acquisition integrates advanced genomics capabilities into Tempus’s AI infrastructure. Completion is expected in late 2026 or early 2027. This move aims to enhance precision oncology testing through improved…